Loading clinical trials...
Loading clinical trials...
The purpose of this study is to test the safety and effectiveness of two experimental therapeutic vaccines against herpes simplex virus, type 2 (HSV-2).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vical
NCT05432583 · Genital Herpes Simplex Type 2
NCT06698575 · Recurrent Genital Herpes Simplex Type 2
NCT02114060 · Genital Herpes Simplex Type 2
NCT02300142 · Genital Herpes Simplex Type 2
Alabama Vaccine Research Clinic
Birmingham, Alabama
Broward Research Group
Hollywood, Florida
Indiana University Infectious Diseases Research
Indianapolis, Indiana
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions